View drug registration information details.
Items | Registration information |
ID | 53 |
No | 53 |
Brand Name | LEVOMET |
Ingredients | LEVODOPA 250 MG, CARBIDOPA MONOHYDRATE 27 MG EQ.TO CARBIDOPA 25 MG |
Dosage Form | TABLET |
Primary Packaging | ALU-PVC/PVDC BLISTER |
Storage | STORE AT TEMPERATURE NOT MORE THAN 30.C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | PRESCRIPTION ONLY |
ATC Classification | N04BA01 |
Pharmaceutical Class | XXX |
Indications | TREATMENT OF IDIOPATHIC PARKINSON'S DISEASE, POSTENCEPHALITIC PARKINSONISM, OR SYMPTOMATIC PARKINSONISM, WHICH MAY FOLLOW INJURY TO THE NERVOUS SYSTEM BY CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION, TO PERMIT ACHIEVEMENT OF SYMPTOMATIC RELIEF WITH A LOWER DOSAGE OF LEVODOPA THAN WITH LEVODOPA ALONE. |
Contraindications | RISK BENEFIT SHOULD BE CONSIDERED WHEN THE FOLLOWING MEDICAL PROBLEMS EXIST: BRONCHIAL ASTHMA, EMPHYSEMA, AND OTHER SEVERE PULMONARY DISEASES… |
Side Effects | - |
Unit Price | - |
EDL |
No |
Description | LIGHT BLUE, OVAL BICONVEX TABLET WITH SCORED ON ONE SIDE AND PLAIN ON THE OTHER |
Note | |
License Owner | AI KEN PHARMA CO., LTD |
Manufacturer | UNISON LABORATORIES CO., LTD |
Country | THAILAND |
Import Registration No | 2A 51/51 |
Import Registration Date | 2008-05-01 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-12-15 |
FDD Registration No | 12 I 3264/08 |
FDD Registration Date | 2023-04-19 |
Expiry Date | 2026-04-18 |
Back to drug list
|